BAY 11-7082 NLRP3 Inflammasome and IkB-alpha Inhibitor
5
$ 11.00
In stock
(422)
Product Description
IJMS, Free Full-Text
Effect of BAY 11-7082 treatment on the NF-κB/Iκb-α pathway. The blot
HIV-1 Tat Primes and Activates Microglial NLRP3 Inflammasome-Mediated Neuroinflammation
Novel Small-Molecule Inhibitor of NLRP3 Inflammasome Reverses Cognitive Impairment in an Alzheimer's Disease Model
The anti‐inflammatory compound BAY‐11‐7082 is a potent inhibitor of protein tyrosine phosphatases - Krishnan - 2013 - The FEBS Journal - Wiley Online Library
Mechanistic and therapeutic role of NLRP3 inflammasome in the pathogenesis of Alzheimer's disease - Jha - Journal of Neurochemistry - Wiley Online Library
Mechanistic and therapeutic role of NLRP3 inflammasome in the pathogenesis of Alzheimer's disease - Jha - Journal of Neurochemistry - Wiley Online Library
Discovery of a Novel Oral Proteasome Inhibitor to Block NLRP3 Inflammasome Activation with Anti-inflammation Activity
Oscillating lncRNA Platr4 regulates NLRP3 inflammasome to ameliorate nonalcoholic steatohepatitis in mice
Discovery of a Novel Oral Proteasome Inhibitor to Block NLRP3 Inflammasome Activation with Anti-inflammation Activity
BAY 11-7082 (BAY 11-7821), IκBα/NF-κB Inhibitor
Cells, Free Full-Text
